BACKGROUND Owing to a growing number of young and adolescent Hodgkin lymphoma
(HL) survivors, awareness of (long-term) adverse effects of anticancer treatment increases …

This paper summarizes current knowledge on ionizing radiation-associated breast cancer in
the context of established breast cancer risk factors, the radiation dose–response …

Background Combined-modality treatment consisting of chemotherapy and consolidation
radiotherapy is standard of care for patients with early-stage unfavourable Hodgkin …

Background Survivors of Hodgkin's lymphoma are at increased risk for treatment-related
subsequent malignant neoplasms. The effect of less toxic treatments, introduced in the late …

Purpose Cardiovascular diseases are increasingly recognized as late effects of Hodgkin
lymphoma (HL) treatment. The purpose of this study was to identify the risk factors for …

Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …

Background Whether it is possible to reduce the intensity of treatment in early (stage I or II)
Hodgkin's lymphoma with a favorable prognosis remains unclear. We therefore conducted a …

Background: Hodgkin lymphoma (HL) survivors are at increased risk for developing valvular
heart disease (VHD). We evaluated the determinants of the risk and the radiation dose …

We assessed cardiovascular disease (CVD) incidence in 1474 survivors of Hodgkin
lymphoma (HL) younger than 41 years at treatment (1965-1995). Multivariable Cox …

Purpose: To assess long-term cause-specific mortality of young Hodgkin's disease (HD)
patients. Patients and Methods: The study population consisted of 1,261 patients treated for …